Our results suggest previous assessments of pathogenic constitutional variants underlying CNS tumor development (in approximately 10% of patients) to appear broadly robust15 and an enrichment of Li–Fraumeni syndrome, Lynch syndrome and constitutional MMR deficiency underlying H3 wild-type HGG. The gene discussed is MRC1; the disease is central nervous system neoplasm.